HOME >> MEDICINE >> NEWS
Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer

Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., South San Francisco, Calif., which manufactures bevacizumab, provided bevacizumab for the trial under the Cooperative Research and Development Agreement (CRADA) with NCI for the clinical development of bevacizumab.

The Data Monitoring Committee overseeing the trial (known as E4599)* recommended that the results of a recent interim analysis be made public because the study had met its primary endpoint of improving overall survival. Researchers found that patients in the study who received bevacizumab in combination with standard chemotherapy (a treatment regimen of paclitaxel and carboplatin) had a median overall survival of 12.5 months compared to patients treated with the standard chemotherapy alone, who had a median survival of 10.2 months. This difference is statistically significant. Detailed results from this trial will be presented at the American Society of Clinical Oncology Annual Meeting (ASCO) to be held in Orlando, Fla., on May 13-17, 2005.

"The exciting results of this randomized study reveal, for the first time, an improvement in survival with the addition of a targeted agent to standard chemotherapy in this patient population," said Study Chair Alan B. Sandler, M.D., of the Vanderbilt University Medical Center in Nashville, Tenn.

"This study demonstrates that mechanistic-based interventions such as angiogenesis inhibitors are making important contribution
'"/>

Contact: NCI Press Officers
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute
14-Mar-2005


Page: 1 2 3

Related medicine news :

1. Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights
2. Detrol LA combined with standard treatment for enlarged prostate is twice as effective
3. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
4. Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
5. Heart disease kills more women annually than all cancers combined
6. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
7. Study shows people with Alzheimers can benefit from exercise combined with caregiver training
8. Wyeth chemists honored for Prevnar first combined pneumococcal vaccine for infants
9. Task force issues caution on combined hormone therapy
10. University of Pittsburgh research shows combined PET/CT finds cancerous lesions standard CT misses
11. Some patients are candidates for combined heart bypass, lung transplant surgeries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... RemetricHealth , a ... the healthcare industry for more than a decade, announced today the launch of ... , In 2010, RemetricHealth, then known as PMD Healthcare, developed the first-ever patented, ...
(Date:5/30/2020)... ... May 30, 2020 , ... HashCash Consultants is working ... meet the needs of a COVID-riddled world, while shaping a robust healthcare infrastructure ... the necessary compliances and augment the caregiving standards through the establishment of an ...
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot ... Howell Michigan, Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki ... patients within the clinic and at the hospital. We have been seeing patients in ...
(Date:5/26/2020)... ... May 26, 2020 , ... Today TRC Companies (“ TRC ”) announced ... that will help business owners and leaders assess whether their organizations are prepared to ... offering from TRC is intended to assist business leaders evaluate their readiness relative to ...
(Date:5/21/2020)... ... , ... In response to the Coronavirus pandemic, Industrial Magnetics, Inc.(IMI) has developed ... doors without using their hands or fingertips. , The new Arm-Pull attaches ... forearm, wrist or elbow when entering or exiting a room. , Perfect for public ...
Breaking Medicine News(10 mins):
(Date:5/30/2020)... ... 30, 2020 , ... Pregnancy is stressful already, and expectant ... to COVID-19. Recently, Wellness Expert Jamie Hess teamed with One A Day® and ... postpartum. , A video accompanying this announcement is available at: https://youtu.be/DikYkcNsD3U ...
(Date:5/28/2020)... ... ... May is Talking is Power Month, a national effort to spark meaningful ... focus of Power to Decide’s #TalkingIsPower campaign reminds parents, trusted adults and other champions ... Piper, MPH, CHES, provides five strategies parents, trusted adults and other champions can use ...
(Date:5/28/2020)... ... May 28, 2020 , ... This new ... , “Notify.com is an acknowledgement-based notification platform,” said Bob Lueth, President of Notify.com. ... PUSH notification, SMS text message, Email or Voice phone call—will be tracked by ...
Breaking Medicine Technology:
Cached News: